These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Episcleritis and scleritis. White GE Optom Clin; 1991; 1(4):79-87. PubMed ID: 1799838 [TBL] [Abstract][Full Text] [Related]
3. Clinical features of patients with episcleritis and scleritis in an Italian tertiary care referral center. Berchicci L; Miserocchi E; Di Nicola M; La Spina C; Bandello F; Modorati G Eur J Ophthalmol; 2014; 24(3):293-8. PubMed ID: 24242216 [TBL] [Abstract][Full Text] [Related]
4. Epidemiology of episcleritis and scleritis in urban Australia. Thong LP; Rogers SL; Hart CT; Hall AJ; Lim LL Clin Exp Ophthalmol; 2020 Aug; 48(6):757-766. PubMed ID: 32279425 [TBL] [Abstract][Full Text] [Related]
5. Episcleritis and scleritis: clinical features and treatment results. Jabs DA; Mudun A; Dunn JP; Marsh MJ Am J Ophthalmol; 2000 Oct; 130(4):469-76. PubMed ID: 11024419 [TBL] [Abstract][Full Text] [Related]
6. [Clinical characteristics of 4 cases of scleritis associated with systemic lupus erythematosus]. Wang L; Yang Y; Jia Y; Miao H; Zhou YS; Zhang XY Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1081-1085. PubMed ID: 27987518 [TBL] [Abstract][Full Text] [Related]
7. [New clinical and epidemiologic aspects of episcleritis and scleritis]. Denk PO; Rohrbach JM; Thiel HJ; Zierhut M Ophthalmologe; 1997 Mar; 94(3):202-5. PubMed ID: 9181836 [TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics of a large cohort of patients with scleritis and episcleritis. Sainz de la Maza M; Molina N; Gonzalez-Gonzalez LA; Doctor PP; Tauber J; Foster CS Ophthalmology; 2012 Jan; 119(1):43-50. PubMed ID: 21963265 [TBL] [Abstract][Full Text] [Related]
9. Posterior Scleritis Following COVID-19 Vaccination: A Case Report. Younus O; Mulla U Ocul Immunol Inflamm; 2023 Apr; 31(3):638-640. PubMed ID: 35226589 [TBL] [Abstract][Full Text] [Related]
10. [Scleritis and episcleritis]. Perray L; Ungerer L; Chazal T; Monnet D; Brézin A; Terrier B Rev Med Interne; 2023 Dec; 44(12):646-655. PubMed ID: 37344292 [TBL] [Abstract][Full Text] [Related]
11. Association of Ocular Adverse Events With Inactivated COVID-19 Vaccination in Patients in Abu Dhabi. Pichi F; Aljneibi S; Neri P; Hay S; Dackiw C; Ghazi NG JAMA Ophthalmol; 2021 Oct; 139(10):1131-1135. PubMed ID: 34473209 [TBL] [Abstract][Full Text] [Related]
12. Orbital myositis and scleritis after anti-SARS-CoV-2 mRNA vaccines: A report of three cases. Savino G; Gambini G; Scorcia G; Comi N; Fossataro C; Stanislao Rizzo Eur J Ophthalmol; 2023 Sep; 33(5):NP29-NP34. PubMed ID: 36062603 [TBL] [Abstract][Full Text] [Related]
13. Syphilitic scleritis and episcleritis: A review. Shields MK; Furtado JM; Lake SR; Smith JR Asia Pac J Ophthalmol (Phila); 2024; 13(3):100073. PubMed ID: 38795870 [TBL] [Abstract][Full Text] [Related]
14. Recurrent Anterior Non-necrotizing Scleritis as an Adverse Event of ChAdOx1 nCoV-19 (Vaxzevria) Vaccine. Hernanz I; Arconada C; López Corral A; Sánchez-Pernaute O; Carreño E Ocul Immunol Inflamm; 2022 Jul; 30(5):1247-1249. PubMed ID: 35394853 [TBL] [Abstract][Full Text] [Related]
15. [Diagnosis and treatment of episcleritis and scleritis]. Tappeiner C; Walscheid K; Heiligenhaus A Ophthalmologe; 2016 Sep; 113(9):797-810. PubMed ID: 27550224 [TBL] [Abstract][Full Text] [Related]
16. [Episcleritis and scleritis. An overview of modern diagnostic and therapeutic concepts]. Denk PO; Thiel HJ; Zierhut M Klin Monbl Augenheilkd; 1997 Sep; 211(3):140-50. PubMed ID: 9445894 [TBL] [Abstract][Full Text] [Related]
17. [Indication and effect of immunosuppression in patients with scleritis]. Heiligenhaus A; Dück N; Michel D; Hudde T; Koch J; Steuhl KP Klin Monbl Augenheilkd; 2003 Jul; 220(7):471-80. PubMed ID: 12886507 [TBL] [Abstract][Full Text] [Related]
18. [Diagnostic and Therapeutic Management of Episcleritis and Scleritis]. Turgut F; Dingerkus V; Tappeiner C; Becker M Klin Monbl Augenheilkd; 2023 May; 240(5):725-738. PubMed ID: 36827997 [TBL] [Abstract][Full Text] [Related]